BillionToOne published a study on cfDNA testing for recessive conditions in over 2,200 pregnant carriers, showing 94.4% sensitivity and 99.5% specificity in detecting fetal risk. The study, conducted across nine U.S. sites, highlights the test's advantage over traditional carrier screening by directly assessing fetal risk without needing partner testing, which is often incomplete. This supports wider use of cfDNA fetal risk assessment in routine prenatal care, offering earlier and more reliable detection of conditions like cystic fibrosis and spinal muscular atrophy. The technology also ensures equitable access across diverse populations and is part of BillionToOne's expanding prenatal screening portfolio.
An analyst from Scotiabank raised the price target for Public Storage (NYSE: PSA) to $346, suggesting a potential 5.75% upside from the current price of $327.18. Institutional investors like Capital Financial Group and Harvest Fund Management have in...
Corporacion America Airports reported Q2 2026 revenue of $534 million, surpassing analyst estimates of $497.52 million, showing strong sales performance. However, earnings per share (EPS) came in at $0.32, below the expected $0.51, indicating lower p...
Analysts have raised their price targets for Cheniere Energy, signaling confidence in the company's future growth. Argus increased its target to $330, suggesting a 20.33% upside from the current price of around $274. TD Cowen also raised its target t...
KeyBanc and DA Davidson upgraded Duolingo's stock rating, citing positive sentiment and raising price targets to $137.11 and $160 respectively. This upgrade lifted Duolingo shares by 4.3% in pre-market trading to $135.71. Despite this optimism, most ...
ReNew Energy Global exceeded analyst expectations in Q1 FY2027 by reporting EPS of $0.17 versus $0.12 estimated and revenue of $506.4 million, surpassing the $459.86 million forecast. The company expanded its renewable energy portfolio to about 20.5 ...
